hotspot -WSS

hotspot

author：entertainment 2025-08-12 09:12:10 - browse：69678

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Was Amgen transparent enough on FDA's concern on cancer drug?

Wikipedia

WSS

Why age limits for politicians are a terrible idea

Large hospital system sues Multiplan for low

Listen: Your guide to Wegovy's blockbuster heart study

FDA rejects Alnylam's heart disease treatment over insufficient data

Analysis of telehealth claims data suggest service duplication

Where are patients getting their prescriptions for GLP

hotspot

hotspot

explore

The cancer drug shortage isn’t new — and neither are the solutions

FDA rejects Alnylam's heart disease treatment over insufficient data

New air purifier tech could be key to improving indoor air quality

White House drug shortages task force keeps mum with Congress

Wildfire smoke exposes gaps in outdoor worker protections

Pharma budget tightening trickles down to Doximity

Drug repurposing or repositioning? The language matters

Faced with fears of OxyContin misuse, sales reps touted its safety

Bright Health sells Medicare Advantage business to Molina

Kim Kardashian sparks debate on benefits of full

focus

Was Amgen transparent enough on FDA's concern on cancer drug?

Covid's long

Kim Kardashian sparks debate on benefits of full

GOP presidential candidates start declaring their loyalty

When women are denied an abortion, their children fare worse than peers

Was Amgen transparent enough on FDA's concern on cancer drug?

leisure time

Wikipedia

Wikipedia

hotspot